BACKGROUND: Sexual dysfunction is a distressing long-term effect after gynecological cancer and affects the majority of survivors for years after the completion of therapy. Despite its prevalence, treatment-related sexual dysfunction is underrecognized and undertreated for survivors. Thus, the aim of this study was to develop and test a brief psychoeducational intervention for managing sexual dysfunction for women who have undergone treatment for ovarian cancer (OC). METHODS: Forty-six OC survivors with documented, treatment-related sexual dysfunction received a single half-day group intervention that included sexual health education and rehabilitation training, relaxation and cognitive behavioral therapy skills to address sexual symptoms, and a single tailored booster telephone call 4 weeks after the group. Assessment measures were completed at the baseline (baseline 1), after an 8-week no-treatment run-in period (baseline 2), and then again 2 and 6 months after the intervention. The Female Sexual Function Index (FSFI) was used to assess sexual functioning, and the Brief Symptom Inventory 18 (BSI-18) was used to capture psychological distress. RESULTS: Between baseline 1 and baseline 2, there were no significant changes in the study measures, and this indicated no natural improvement during the run-in period. In contrast, the total FSFI scores improved significantly from baseline 1 to the 2-(n 5 45; P <.0005) and 6-month time points (n 5 42; P <.05). The BSI-18 scores were also significantly improved at the 2-(P <.005) and 6-month time points (P <.01) in comparison with baseline 1. CONCLUSIONS: This brief behavioral intervention led to significant improvements in overall sexual functioning and psychological distress that were maintained at the 6-month follow-up. The results demonstrate the feasibility of this brief, low-intensity behavioral intervention and support the development of a larger randomized controlled trial. Cancer 2018;124:176-82.
INTRODUCTION
Female cancer survivors often face distressing and severe sexual side effects related to their disease and its treatments. [1] [2] [3] For gynecological cancer survivors, sexual dysfunction has been identified as one of the core set of quality-of-life domains that is profoundly disrupted after treatment. 4 Common detrimental problems include diminished arousal, vaginal dryness, a loss of sexual desire, and decreased satisfaction. In addition to the physiological impact of gynecological cancer treatment, women suffer from a range of related psychological consequences such as a perceived loss of femininity, negative body image, and psychological distress. 5 With advances in chemotherapy and surgical techniques over the past decade, nearly 50% of women diagnosed with ovarian cancer (OC) can expect to live for many years after the diagnosis. [6] [7] [8] [9] However, treatment regimens for OC are intensive and often include multiple surgeries and repeated courses of chemotherapy. 8 The resulting sexual dysfunction from OC treatment is particularly severe, 10 and it has been described as the "most enduringly compromised quality-of-life (QOL) issue" 5 for this group of women. Because of the growing number of long-term gynecological cancer survivors, 1 including OC survivors, who may live for years on and off chemotherapy, 7 there is a pressing need to address these sexual side effects of treatment that negatively affect the quality of life. 11 Despite recent calls to address sexual dysfunction for gynecological cancer survivors, there are no standardized treatments routinely recommended. In fact, the majority of gynecological cancer survivors report that sexual problems are rarely addressed by their providers. 12 One reason that clinicians may not routinely discuss this topic with patients is a lack of available resources for managing sexual problems. 13, 14 Fortunately, there is a growing interest in developing interventions for cancer-related female sexual dysfunction. 15 Examples include pharmacologic interventions to address the physical side effects of menopause [16] [17] [18] [19] and counseling interventions to address psychosocial adjustments 20, 21 (eg, peer counseling 22 or couples counseling 23, 24 after breast cancer.
Although sexual function is a multifactorial experience composed of physical, psychological, and social elements, 25, 26 one major limitation of interventions to date is that most have addressed either physical or psychological consequences of treatment. 15 Moreover, counseling interventions have generally relied on resource-and timeintensive methods (eg, individual counseling sessions or multiple-session formats [27] [28] [29] , and most have been designed for partnered women only. Recent examples are a 4-session counseling intervention for rectal and anal cancer survivors that included an additional counseling telephone call after each session 30 and a Web-based program for breast cancer survivors in which women worked with a professional counselor online and were guided through a range of up to 20 teaching modules over the course of 24 weeks. 31 Informed by these efforts as well as recent innovations demonstrating the efficacy of group interventions for promoting sexual health rehabilitation, 26, 32, 33 we recently delivered a successful single-session sexual health intervention for women who had undergone prophylactic oophorectomy for breast cancer/OC risk reduction. 34 In that intervention, our goal was to develop a model of brief, group-based treatment 26, 35 that integrates targeted sexual health education 36, 37 with pelvic floor awareness and relaxation training as well as elements of mindfulnessbased cognitive therapy 38 to improve sexual function and decrease distress in women with treatment-related sexual dysfunction. Given the paucity of interventions available for OC survivors, we chose to adapt that low-intensity intervention for women after oophorectomy and test the delivery in a population of OC survivors with sexual dysfunction.
MATERIALS AND METHODS

Participants and Recruitment
Women were eligible to participate if they had been treated for OC (stages I-IV) and reported being bothered by at least 1 of the following symptoms: loss of sexual interest, difficulty in becoming sexually aroused, loss of enjoyment in sexual activity, vaginal dryness or tightness, and pain or discomfort during sexual activity. These items were drawn from the Sexual Functioning Scale of the Sexual Function Questionnaire. 39 In addition, women had to be deemed to have no significant functional challenges, as assessed by 3 functional assessment items from the EuroQol 5-dimension questionnaire, a standardized measure of functional health status. 40 Specifically, if a patient endorsed being 1) unable to perform usual activities, 2) unable to walk about as usual, and/or 3) unable to wash or dress/perform usual self-care, she was considered ineligible to participate. Women were excluded if they were unable to speak English or had a history of pelvic radiation. The intervention was open to all women regardless of their partner status or sexual orientation. Potential participants were identified through gynecology oncology clinics at the Dana-Farber Cancer Institute and through direct referrals from gynecological oncology surgeons and oncologists. Information about the study was also disseminated to community support groups for OC survivors in the greater Boston metropolitan area. Women identified from clinics or oncology providers were sent recruitment letters that contained a participation form and a toll-free opt-out telephone number. The Dana-Farber Cancer Institute's institutional review board approved the study, and all participants provided written consent. The study was registered with the Office of Clinical Trials on November 4, 2014 (NCT02287519).
Intervention Design and Content
The intervention was composed of a single half-day psychoeducational group session, take-home educational materials, and a single booster telephone call. Patientreported assessments of sexual health and psychological functioning were completed at 4 time points. Women filled out initial baseline measures 6 to 8 weeks before the scheduled intervention group (baseline 1). After this runin period, baseline questionnaires were again filled out inperson immediately before the psychoeducational session (baseline 2). Follow-up measures were assessed by mail 2 (follow-up 1) and 6 months (follow-up 2) after the intervention. Upon the completion of each postintervention packet, the participants received a $25 gift certificate. Written informed consent was obtained from all participants at the group sessions.
Psychoeducational session
Based on a clinical workshop approach, the single 3.5-hour group session was structured around 4 primary modules and facilitated by the lead investigator (S.L.B.), a clinical psychologist and expert in sexual rehabilitation after cancer treatment. Module 1 focused on sexual health information and education about treatment-related sexual problems, such as improving vaginal health and low desire. Additional education included strategies for communicating about sexual problems, such as how to talk to one's treatment team. Module 2 focused on relaxation training and body awareness. Women learned about the pelvic floor and strategies for pelvic floor relaxation. They were also guided through a muscle-relaxation exercise. Plain and straightforward language was used to discuss sexual problems, and slides also contained useful visual representations such as a model of the pelvic floor musculature. Module 3 was guided by principles of mindfulness-based cognitive therapy. In this module, women learned about the interplay of thoughts, feelings, and behavior and were guided through 2 exercises: one that allowed practicing nonjudgmental curiosity about thoughts and feelings and another that allowed them to identify and reframe negative automatic thoughts. The content of module 4 was focused on individual-based activity planning, in which women identified problems and personal goals and created a plan including at least 2 actionable steps to try during follow-up that was based on what they had learned; the expectation was that the goals and action plan would be reviewed during the postgroup telephone booster.
Take-home educational materials and telephone booster
Women received educational materials during the group session to help to clarify and consolidate information from the session. Materials included instructions for a mindfulness-based body scan 41 and muscle-relaxation exercises 42 and information about personal products such as vaginal moisturizers and dilators as well as resources for sexual health Web sites and books. Approximately 1 month after the group session, each woman received a single brief telephone booster intended to support the completion of her personal action plan. The booster calls were made by a trained intervention assistant who attended the intervention workshop, and they lasted approximately 15 minutes. During each call, the assistant reviewed the participant's action plan and offered encouragement for continued engagement. The assistant was also able to refer women back to relevant resources to address outstanding questions or barriers.
Main Outcome Measures
Female Sexual Function Index (FSFI)
The FSFI was administered to assess current sexual functioning. The 19-item FSFI measures 5 domains: 1) Desire, 2) Lubrication, 3) Orgasm, 4) Pain, and 5) Satisfaction. Women rate each item on a 5-point Likert scale, and scores range from 2 to 36, with a higher score indicating better sexual function. The FSFI's total and domain scores have been shown to be reliable and valid measures of sexual function for both noncancer 43 and cancer survivor populations. 44 A total score less than 26.55 (the cutoff score) clinically indicates sexual dysfunction. 45 
Brief Symptom Inventory 18 (BSI-18)
The BSI-18 is a widely used, well-validated brief measure of psychological distress that has been used extensively in oncology populations. 46 The 18 items form the Global Severity Index, which reflects general psychological distress, and 3 subscales: 1) Somatization, 2) Depression, and 3) Anxiety. Each item contains a 5-point Likert scale. A higher score indicates increased psychological distress.
Participant satisfaction
Participants completed an 8-item satisfaction rating form about the group session, Participants also rated the intervention content in terms of understandability and overall helpfulness. Items were rated on a 5-point Likert scale.
Statistical Analyses
Descriptive statistics were used to summarize participants' demographic and medical information as well as their responses on the FSFI and BSI-18. To examine the changes in participants' sexual and emotional functioning over the course of the study period, a series of withinsubjects analyses of variance were conducted for each of the study outcome measures (FSFI and BSI-18), and Cohen's d was calculated as a measure of the effect size. Each analysis of variance tested the hypothesis that participants' scores did not differ significantly across the 4 time periods. For each analysis of variance, if the omnibus F test was statistically significant and thus indicated that participants' scores were not constant over the study period, this null hypothesis was rejected, and Dunnett's test was applied as a post hoc analysis. Dunnett's test, a series of pairwise means comparisons, was used to compare participants' scores at the baseline with their scores in each subsequent time period. All tests were 2-sided, and a was set at .05. SPSS software (version 24) was used for all analyses.
RESULTS
Recruitment and Study Participation
Ninety-nine women who were identified as interested and potentially eligible were screened for participation in the study. Of these 99 women, 72 were eligible, and 53 enrolled in the study (they consented and filled out the baseline questionnaires). Seven women declined participation before attending a group. The primary reasons for refusal included 1) the timing of the group session, 2) being too busy, and 3) distance. Forty-six women Original Article attended a group session. Forty-five women completed the follow-up 1 survey (98% completion rate). Of the 46 women who participated in a group, 42 completed the follow-up 2 survey (2 women died, and 2 were lost to follow-up). The study response rate was similar to other intervention response rates for female sexual dysfunction after cancer.
36,47
Study Sample Characteristics
The demographic and medical characteristics of the 46 women who participated in a group are shown in Table 1 . At the baseline, the participants had a mean age of 55.8 years (standard deviation, 10.29 years; range, 27-74 years), and they were a mean of 6.26 years (standard deviation, 5.34 years; range, 1-20 years) from their diagnosis. Table 2 shows participants' mean scores for the FSFI and BSI-18 at the baseline and after the intervention. Table 2 shows the means and standard deviations of the FSFI and BSI scores from the run-in period (from baseline 1 to baseline 2). Overall, these scores remained stable over the 2-month period; there were no significant changes in either sexual function or psychological distress.
Sexual Function and Distress Before the Intervention
Effect of the Intervention on Sexual Function
As shown in Table 2 , participants experienced significant changes in sexual function over time, before and after the intervention, in the FSFI total score (P < .0005; d 5 0.47) and FSFI subscale scores, including Arousal (P < .0005; d 5 0.45), Orgasm (P < .0005; d 5 0.48), Lubrication (P 5 .003; d 5 0.47), and Satisfaction (P < .0005; d 5 0.44). Post hoc analyses revealed significant improvements in both overall sexual function and the Arousal, Lubrication, Orgasm, and Satisfaction subscales from baseline 1 to follow-up 1 (also shown in Table 2 ). The magnitude of the change observed between baseline 1 and follow-up 1 approached the moderate range, with the effect sizes on both the FSFI total score and the subscale scores varying between 0.44 and 0.48. The magnitude of the change in the Desire subscale was smaller (0.33).
Moreover, post hoc analyses additionally showed that both overall sexual function and the Arousal, Lubrication, Orgasm, and Satisfaction subscales continued to be significantly improved at follow-up 2 in comparison with the baseline (Table 2 ). The Desire subscale showed a trend toward improvement at follow-up 1 and demonstrated statistically significant improvement at follow-up 2 in comparison with the baseline (Table 2) .
Effect of the Intervention on Psychological Distress
As shown in Table 2 , participants experienced significant reductions in psychological distress over time according to the Global Severity Index (P 5 .001; d 5 0.47) as well as the Depression (P 5 .004; d 5 0.46) and Somatization subscales (P 5 .030; d 5 0.23). Post hoc comparisons revealed significant improvements in both the Global Severity Index and the Depression subscale from baseline 1 to follow-up 1 ( Table 2 ). The magnitude of the change between baseline 1 and follow-up 1 in the Global Severity Index and the Depression subscale similarly approached the moderate range with scores of 0.47 and 0.46, respectively. At followup 2, the Global Severity Index showed continued significant improvement, as did the Depression subscale. In addition, the Somatization subscale showed significant improvement between baseline 1 and follow-up 2.
Participant Satisfaction
Ninety-six percent of the participants reported that they enjoyed participating in the psychoeducation group session, and 98% agreed that the group session gave helpful information for addressing treatment-related sexual problems. All participants felt that the content of the group session was easy to understand, and 98% of the participants reported feeling satisfied with the content of the group session. During the group, many women also spontaneously expressed a sense of relief that they were not alone in struggling with these problems.
DISCUSSION
We evaluated the effect of a brief behavioral intervention for OC survivors who met criteria for distressing sexual dysfunction. This low-intensity psychosexual intervention resulted in significant improvement in overall sexual function in a group of OC survivors who, on average, had been diagnosed more than 6 years before the intervention. Significant improvements were also observed in several important sexual function domain subscales, including Desire, Arousal, Orgasm, and Lubrication. Results from the 8-week run-in period additionally lend support for the understanding that, unlike other treatment-related side effects, sexual problems do not self-resolve but instead stay the same or potentially worsen over time. 48, 49 The intervention also significantly reduced psychological distress in this group of survivors.
Moreover, the magnitude of the effect sizes detected from this single-session intervention approached the moderate range, with most effect sizes having a value greater than 0.44 on measures of both sexual function and psychological distress. Although most interventions for sexual sequelae of cancer have not reported on the magnitude of the change, 15 the effect sizes from this study are comparable to or larger than the small to moderate effect sizes previously observed with other more intensive behavioral interventions that also used the FSFI as a primary outcome measure. 15, 23 Notably, positive improvements were maintained at the 6-month follow-up, and this suggests that the changes resulting from this brief, lowintensity intervention are lasting.
Although the content of the intervention was primarily aimed at improving sexual function, it is also noteworthy that the intervention had a significant beneficial impact on reducing psychological distress, including symptoms of depression. There is increasing evidence that sexual function is strongly correlated with health-related quality of life in general 30, 50 and that improvements in sexual health are similarly tied to improvements in quality of life. 22 Our observation that psychological distress, measured by both the general full-scale score and the Somatization subscale, continued to further improve between 2 and 6 and months of follow-up was also striking. One potential explanation is that behavioral changes that women committed to trying initially may have been maintained over the 6-month follow-up period, and this in turn continued to have an ongoing positive effect on mood and psychological well-being. These results underscore our observation that when women receive an integrative intervention that conveys skill-based strategies along with coping tools and a personalized action plan, both sexual health and psychological quality of life are enhanced. This is the first study, to our knowledge, to explore the effect of a brief, single-session intervention designed to address sexual sequelae of gynecological cancer, including both physical and psychological components. Both the low-intensity nature and the integrative content of the intervention stand in contrast to previous female sexual health interventions after cancer. Results from this intervention support the hypothesis that a brief, group-based intervention can provide a useful and effective format for sexual rehabilitation for women after gynecological cancer. The limitations of this intervention included the use of a relatively small sample of mainly white, collegeeducated women, which thus potentially limited the generalizability of these findings to other more diverse groups of survivors. Although the results of this intervention are promising, the lack of a traditional control group limits our ability to definitively conclude that improvements in sexual function were not due merely to the passage of time. However, consistent with prior studies, 5,51 the results from the run-in period in this study do suggest that time alone does not ameliorate sexual side effects. Future studies that randomize participants to a control condition could evaluate this question more thoroughly. The relative stability of scores on the FSFI Pain subscale additionally raises an important question for future study. It is possible that the symptom of pain requires more intensive intervention, or alternatively, this finding may also reflect a limitation in measurement. That is, it may not be clinically most meaningful to simply assess the presence of pain or discomfort with sexual activity. In contrast, it may be more meaningful to capture women's ability to adequately manage pain or discomfort with respect to interference with sexual satisfaction. Lastly, it is important to acknowledge that the in-person group intervention format precluded some prospective participants from attending a session because of distance and scheduling issues. Future studies should explore how this intervention may be developed into a more portable platform, such as administration via an online format (eg, a webinar).
The strengths of our intervention include an innovative approach that addresses sexual dysfunction in a brief, low-intensity group setting. These promising results also set the groundwork for future studies that may assess applicability to women who suffer from other types of treatment-related sexual dysfunction. An additional important clinical implication is that when providers have resources to offer patients suffering from treatmentrelated sexual dysfunction, they are more likely to broach this topic.
14 Thus, with the availability of a brief and effective treatment for treatment-related sexual problems, providers may feel more encouraged to address this fundamental quality-of-life domain that is disrupted and enormously compromised for the majority of female cancer survivors.
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